Sp. Robinson et al., NONINVASIVE MONITORING OF CARBOGEN-INDUCED CHANGES IN TUMOR BLOOD-FLOW AND OXYGENATION BY FUNCTIONAL MAGNETIC-RESONANCE-IMAGING, International journal of radiation oncology, biology, physics, 33(4), 1995, pp. 855-859
Citations number
33
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: The response of tumors to radiotherapy can be enhanced if car
bogen (95% O-2, 5% CO2) is breathed. The timing of carbogen administra
tion is critical, and a noninvasive method of monitoring the response
of individual tumors would have obvious utility. Functional gradient r
ecalled echo (GRE) magnetic resonance imaging (MRI) techniques are sen
sitive to changes in the concentrations of deoxyhemoglobin, which, thu
s, acts as an endogenous contrast agent for oxygenation status and blo
od flow. Methods and Materials: Subcutaneous GH3 prolactinomas in thre
e rats were imaged at 4.7 Tesla with a GRE H-1 sequence [echo time (TE
) = 20 ms, repetition time (TR) = 80 ms, hip angle = 45 degrees, 1 mm
slice, 256 phase encode steps, 4 cm field of view, in-plane resolution
0.08 x 0.08 mm, acquisition time = 4 min]. The rats breathed air or c
arbogen for four periods of 20 min; three control rats breathed only a
ir. Results: Carbogen breathing caused increases of up to 100% in the
GRE image intensity of the tumors. Reversion to air breathing caused t
he image intensity to fall; essentially the same response was observed
with the second cycle of carbogen and air breathing. Control rat tumo
rs showed no significant change. Conclusions: The response of tumors t
o carbogen can be monitored noninvasively by GRE MRI. In principle, th
is could be due to an increase in oxygen content of the blood, a decre
ase in tumor cell oxygen consumption, or an increase in tumor blood fl
ow. The very large changes in signal intensity suggest that a blood fl
ow increase is the most probable explanation. If this technique can be
successfully applied in man, it should be possible to optimize carbog
en treatment for individual radiotherapy patients, and perhaps also to
enhance tumor uptake of chemotherapeutic agents.